Update on genetics of stroke and cerebrovascular disease 2005.
Markus
Hugh S
HS
The Clinical Neuroscience, St Georges, University of London, London, UK. h.markus@sgul.ac.uk
Alberts
Mark J
MJ
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000235:genetics; D058927:5-Lipoxygenase-Activating Proteins; D046589:CADASIL / Q000235:genetics*; D002352:Carrier Proteins / Q000235:genetics; D002561:Cerebrovascular Disorders / Q000235:genetics*; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4; D005192:Family Health; D008040:Genetic Linkage / Q000235:genetics; D006801:Humans; D002532:Intracranial Aneurysm / Q000235:genetics*; D008565:Membrane Proteins / Q000235:genetics; D009154:Mutation; D016017:Odds Ratio; D011110:Polymorphism, Genetic; D012307:Risk Factors; D020521:Stroke / Q000235:genetics*; D013345:Subarachnoid Hemorrhage / Q000235:genetics*
D058927:5-Lipoxygenase-Activating Proteins; C548592:ALOX5AP protein, human; D002352:Carrier Proteins; D008565:Membrane Proteins; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4